Predicting islet yield in pediatric patients undergoing pancreatectomy and autoislet transplantation for chronic pancreatitis.
Predicting islet yield in pediatric patients undergoing pancreatectomy and autoislet transplantation for chronic pancreatitis.
复制标题
DOI:
10.1111/j.1399-5448.2009.00575.x
复制
发表时间:
2010-06
影响因子:
3.4
通讯作者:
Moran A
中科院分区:
文献类型:
--
作者:
Bellin MD;Blondet JJ;Beilman GJ;Dunn TB;Balamurugan AN;Thomas W;Sutherland DE;Moran A
Chronic pancreatitis (CP) in children is associated with significant morbidity and can lead to narcotic dependence. Total pancreatectomy (TP) may be indicated in refractory CP to relieve pain; simultaneous islet autotransplant (IAT) may prevent postsurgical diabetes. About half of pediatric patients are insulin independent 1 yr after IAT. Insulin independence correlates best with the number of islets available for transplantation (islet yield). Currently there is no known method to predict islet yield in a given patient. We assessed the ability of preoperative metabolic tests to predict islet yields in 10 children undergoing TP/IAT. Hemoglobin A1c (HbA1c) and mixed meal tolerance tests (MMTT) were obtained prior to surgery in 10 patients age ≤ 18 yr. Fasting glucose, C-peptide, and creatinine were used to calculate the C-peptide to glucose* creatinine ratio (CPGCR). C-peptide peak and area under the curve (AUC) were determined from 2 h MMTT. Linear regressions were performed to predict islet yield from baseline test results. Islet yield ranged from 7000 to 434 000 islet equivalents (IE) (mean 222 452 ± 148 697 IE). Islet yield was well predicted from body weight and fasting plasma glucose (R2 = 57%, adjusted for overfitting by bootstrap). Islet yield was positively associated with CPGCR, peak C-peptide, and AUC C-peptide and negatively associated with HbA1c. Pilot data from 10 pediatric patients suggest that simple preoperative measurement of fasting plasma glucose may give a useful prediction of islet yield. Islet yield correlates with HbA1c and C-peptide levels. This information allows individual candidates to weigh the specific risk of becoming diabetic against the benefit of pain relief should they undergo TP-IAT.
登录
查看更多内容
DOI:
10.1097/mpg.0b013e31815cbaf9
发表时间:
2008-07-01
影响因子:
2.9
作者:
Bellin, Melena D.;Carlson, Annelisa M.;Sutherland, David E. R.
通讯作者:
Sutherland, David E. R.
DOI:
10.1007/bf02581331
发表时间:
1990-07-01
期刊:
ACTA DIABETOLOGICA LATINA
影响因子:
--
作者:
RICORDI, C;GRAY, DWR;LACY, PE
通讯作者:
LACY, PE
影响因子:
--
作者:
Lowe, Mark E
通讯作者:
Lowe, Mark E
影响因子:
3.3
作者:
Lakey, JRT;Warnock, GL;Rajotte, RV
通讯作者:
Rajotte, RV
影响因子:
8.8
作者:
Hering, BJ;Kandaswamy, R;Bluestone, JA
通讯作者:
Bluestone, JA